Skip to Main Content

Author Details

Maya Ghoussaini
Wellcome Sanger Institute
2005
55
35
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36399499The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.Nucleic Acids Res2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37308670Mapping interindividual dynamics of innate immune response at single-cell resolution.Nat Genet2023
36963162Future prospects for human genetics and genomics in drug discovery.Curr Opin Struct Biol2023
35772218Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.EBioMedicine2022
35804044Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs.Nat Rev Drug Discov2022
33045747Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics.Nucleic Acids Res2021
33664506Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation.Nat Genet2021
34402426A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.Elife2021
34711957An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci.Nat Genet2021
34146516Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.Am J Hum Genet2021
34083789A map of transcriptional heterogeneity and regulatory variation in human microglia.Nat Genet2021
33196847Open Targets Platform: supporting systematic drug-target identification and prioritisation.Nucleic Acids Res2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33289971Mining a GWAS of Severe Covid-19.N Engl J Med2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33289972Mining a GWAS of Severe Covid-19.N Engl J Med2020
29633761Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Nat Commun2018
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
29059683Association analysis identifies 65 new breast cancer risk loci.Nature2017
26928228Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Nat Genet2016
27640304Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Am J Hum Genet2016
27601076Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Nat Commun2016
27600471Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).Sci Rep2016
27117709Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.Nat Commun2016
27459855Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.Breast Cancer Res2016
27087578Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.Int J Cancer2016
25168388Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.Hum Mol Genet2015
26354892Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.Cancer Epidemiol Biomarkers Prev2015
26073781Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.Am J Hum Genet2015
25652398Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.Hum Mol Genet2015
25529635Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.Am J Hum Genet2015
25248036Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Nat Commun2014
23540573Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.Am J Hum Genet2013
24290378Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.Am J Hum Genet2013
23973388Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning?Am J Pathol2013
23778136Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features.J Clin Invest2013
23535731Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet2013
23535732Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.Nat Genet2013
23535729Large-scale genotyping identifies 41 new loci associated with breast cancer risk.Nat Genet2013
22267197Genome-wide association analysis identifies three new breast cancer susceptibility loci.Nat Genet2012
228593999q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2012
21814516A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.PLoS Genet2011
20075856Analysis of the SIM1 contribution to polygenic obesity in the French population.Obesity (Silver Spring)2010
20852631A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.Nat Genet2010
20453838Genome-wide association study identifies five new breast cancer susceptibility loci.Nat Genet2010
19519208Polygenic susceptibility to breast cancer: current state-of-the-art.Future Oncol2009
19401419Common variation in SIM1 is reproducibly associated with BMI in Pima Indians.Diabetes2009
19330027Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.Nat Genet2009
  • 1 - 50 of 55

Recommended Authors

Jingxiong Xu
Lunenfeld-Tanenbaum Research Institute
Career Start Year 2014
Number of shared co-authors 3
Eric R Gamazon
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 34
Daryl Waggott
Ontario Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 18
Karol Estrada
Brandeis University
Career Start Year 2009
Number of shared co-authors 21
Xiangjun Xiao
Institute for Clinical and Translational Research, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 37
Younghun Han
Institute for Clinical and Translational Research, Baylor College of Medicine
Career Start Year 2007
Number of shared co-authors 95
Swneke D Bailey
Research Institute of the McGill University Health Centre
Career Start Year 2006
Number of shared co-authors 7
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 35
Benjamin F Voight
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2005
Number of shared co-authors 28
Sarah S Murray
University of California San Diego Health System
Career Start Year 2004
Number of shared co-authors 21
Scott J Hebbring
Marshfield Clinic Research Institute
Career Start Year 2003
Number of shared co-authors 29
Andrew D Skol
The University of Chicago
Career Start Year 2001
Number of shared co-authors 10
Stacey Gabriel
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 33
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 55
Andrew P Morris
The University of Manchester
Career Start Year 1997
Number of shared co-authors 71
Mathieu Lemire
The Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 33
Laurent Briollais
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Career Start Year 1996
Number of shared co-authors 12
Dakai Zhu
The Institute for Clinical and Translational Research, Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 13
Unnur Thorsteinsdottir
University of Iceland
Career Start Year 1995
Number of shared co-authors 64
Carolyn M Hutter
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 26
Panos Deloukas
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1992
Number of shared co-authors 51
David A Hinds
23andMe Inc.
Career Start Year 1992
Number of shared co-authors 31
Thomas J Hudson
Ontario Institute for Cancer Research
Career Start Year 1991
Number of shared co-authors 72
Gudmar Thorleifsson
deCODE genetics/Amgen Inc.
Career Start Year 1991
Number of shared co-authors 63
Joel N Hirschhorn
Broad Institute of MIT and Harvard
Career Start Year 1988
Number of shared co-authors 53
Albert V Smith
University of Michigan School of Public Health ann arbor
Career Start Year 1987
Number of shared co-authors 62
Mark J Daly
Massachusetts General Hospital
Career Start Year 1987
Number of shared co-authors 55
Konstantin Strauch
German Research Center for Environmental Health, Institute of Genetic Epidemiology
Career Start Year 1986
Number of shared co-authors 56
Struan F A Grant
Center for Spatial and Functional Genomics, The Children's Hospital of Philadelphia
Career Start Year 1984
Number of shared co-authors 46
Elizabeth M Gillanders
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 78

Collaborators

Douglas F Easton
University of Cambridge
Co-authored papers 32
Alison M Dunning
Co-authored papers 31
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 29
Graham G Giles
Co-authored papers 28
Jan Lubinski
Pomeranian Medical University
Co-authored papers 27
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 25
Fergus J Couch
Mayo Clinic
Co-authored papers 25
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 25
Irene L Andrulis
University of Toronto
Co-authored papers 25
Christopher A Haiman
University of Southern California
Co-authored papers 25
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 25
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 24
Roger L Milne
Co-authored papers 24
Diether Lambrechts
Co-authored papers 24
Per Hall
Co-authored papers 24
Hoda Anton-Culver
University of California irvine
Co-authored papers 24
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 23
Xiao-Ou Shu
Co-authored papers 22
Wei Zheng
Co-authored papers 22
Loic Le Marchand
Co-authored papers 22
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 20
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 20
Qiuyin Cai
Co-authored papers 19
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 19
Julia A Knight
Co-authored papers 19
Anna H Wu
University of Southern California
Co-authored papers 19
Børge G Nordestgaard
Co-authored papers 19
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 19
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 18
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers 18
Release 1.2